XNAS
KARD
Market cap1.83bUSD
Jul 31, Last price
20.82USD
1D
1.71%
Name
Kardigan Inc
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Valuation
No data to show